logo
Cats Have Given Alzheimer's Scientists Hope For Breakthrough Research

Cats Have Given Alzheimer's Scientists Hope For Breakthrough Research

Yahooa day ago
A study recently published in the European Journal of Neuroscience has found that cats appear to develop a version of dementia in similar ways to humans.
Feline cognitive dysfunction syndrome (also known as feline dementia) tends to develop as cats age. It affects their sleep, socialising, and sense of orientation.
As with humans, feline dementia seems to include a buildup of amyloid-beta proteins.
Per the new paper, cats with feline cognitive dysfunction syndrome also experience 'brain atrophy, neuronal loss, amyloid-beta plaques, tau pathology and cerebral amyloid angiopathy' – all processes suspected to be a part of human dementia development.
Why might this finding in cats help people with dementia?
The University of Edinburgh scientists looked at the brains of 25 cats who had died. They were of different ages, and some had 'feline dementia'.
After looking at 'powerful microscopy images', the researchers found a higher amyloid plaque buildup between the synapses of older cats and those with feline dementia.
The team also found that some cells in the brain engulfed, or 'ate', affected synapses (sometimes known as synaptic pruning).
Though this process is often helpful to keeping your brain healthy, in those with dementia, the loss of these synapses 'strongly predicts reduced memory and thinking abilities in humans with Alzheimer's disease', the University of Edinburgh explained.
The scientists say the apparent similarity between cat and human dementia development means felines could provide a 'naturally occurring, translational' model of dementia for future researchers.
Dr Robert McGeachan, the study's lead author, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs.
'Because cats naturally develop these brain changes, they may... offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregiver.'
Will this help cats with dementia, too?
The researchers highlighted the potential to help our pets with dementia through future research as well.
Professor Danièlle Gunn-Moore, a co-author of the study, said: 'Feline dementia is so distressing for the cat and for its person. It is by undertaking studies like this that we will understand how best to treat them.
'This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. Feline dementia is the perfect natural model for Alzheimer's; everyone benefits.'
Related...
This Exercise Type May Reduce Dementia Risk By 88%
This Lifestyle Change May Delay Dementia And Heart Disease As You Age
Today's 70-Year-Old's Less Likely To Have Dementia Than Past Generations – Is This Why?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Decoding The Molecular Benefits Of Exercise
Decoding The Molecular Benefits Of Exercise

Forbes

time29 minutes ago

  • Forbes

Decoding The Molecular Benefits Of Exercise

There has always been a dream that there could be a pill to replace exercise. New research suggests a molecule called betaine, naturally produced by the kidneys, may do just that. According to a new study published in Cell, it may mimic many of the health-protective effects of exercise. This suggests that it could help protect against aging-related decline, even in individuals who are unable to maintain regular physical activity. Betaine is produced by the kidneys. Previous research has linked it to cardiovascular health and liver function, but its role in geroprotection has been underappreciated. This research shows the kidney acts as a command center in exercise-driven rejuvenation. Betaine directly inhibits key drivers of inflammation, silencing 'inflammaging'—chronic inflammation that accelerates cellular aging. This links movement at the gym to age-defying changes in cellular Molecular Language of Movement Decades of research have linked regular exercise to longer lifespans and reduced risk for inflammation-driven diseases. Therefore, we know exercise is beneficial, but the mechanisms—what actually changes at the microscopic level—are not well understood. For example, activities such as running, cycling or resistance training have a positive effect on metabolism and heart health. Recent advances now enable us to investigate the molecular changes underlying these improvements. This new study presents a systematic, cell-by-cell analysis. It looks at how both acute and sustained exercise drive rapid shifts in molecular signatures, redefining our understanding of 'exercise as medicine'. The study tracked 13 healthy human volunteers over periods of rest, a single 5-km run, and long-term training in the form of 25 days of running. During these periods, samples were collected. These examined how the body's cells and molecules responded. More specifically, the study went beyond general health markers. It used advanced techniques, such as single-cell sequencing, to determine which genes are activated in individual cells during exercise. It also measures proteins, small molecules related to metabolism and it studies the gut microbiome. To explain this in simpler terms, you might compare this to a car tune-up. Even short, regular sessions of exercise prompt the body to 'fix' and 'upgrade' its cellular machinery, leading to wide-ranging health improvements. The study's use of sophisticated technology is like opening the hood and not just checking the oil, but inspecting every engine part for improvement. These tests and samples provide an unprecedented, detailed insight into the body's inner workings in response to exercise. The findings show that a single workout triggers a short burst of inflammation, described as 'metabolic chaos,' that helps the body adjust to sudden physical stress. Sustained exercise, on the other hand, reprograms the body towards youthfulness, reshapes the gut microbiome, enhances antioxidant activity, promotes DNA stability in immune cells and elevates betaine Path Forward in Understanding the Molecular Benefits of Exercise These results build upon prior work linking exercise to reductions in cellular senescence, tissue inflammation, and metabolic disease—all key hallmarks of aging. What distinguishes this research is the identification of a single, kidney-derived metabolite that can orchestrate what is known as systemic geroprotection. Consider the case of elderly patients facing joint pain or disability. They are often unable to engage in adequate physical activity. Betaine supplementation, pending further clinical validation, could potentially offer a pharmacological lifeline to healthspan extension, helping these individuals maintain independence and quality of life without the barrier of vigorous exercise. That said, the study tested only a small, similar group of people, so we can't be sure the results apply to everyone. The limited sample size and lack of participant diversity mean that the findings may not be generalizable to broader populations. Still, the early results are promising. As research moves from bench to bedside, we approach an era where the secrets of exercise may be unlocked—and replicated—to benefit all.

Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates
Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates

Yahoo

timean hour ago

  • Yahoo

Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates

The global recombinant human hair keratin protein market is growing quickly as more people seek effective hair health solutions and advanced wound healing treatments, says a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The global recombinant human hair keratin protein market is on a strong growth trajectory, with revenues expected to climb into the hundreds of millions by 2034. This momentum is being fueled by a rising focus on hair health, a noticeable increase in bleeding disorder cases, and a wave of fresh investments pouring into biotechnology. Together, these factors are creating fertile ground for innovation and demand across multiple industries. Companies in North America, Asia-Pacific, and Europe are actively investing in research, driving innovations, and forming partnerships to open new market opportunities. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the recombinant human hair keratin protein market in 2024. Asia Pacific is estimated to grow at the fastest CAGR during the forecast period. Market Overview & Potential Recombinant human hair keratin protein is a lab-engineered protein that replicates the structure and function of natural keratin in human hair. It is produced via recombinant DNA technology, resulting in a highly controlled and pure form of keratin that differs from traditional extracts. This makes it a valuable material for applications such as wound healing and hair care. Conventional keratin extraction methods can be inconsistent and may not yield pure products, whereas recombinant production ensures greater purity and enables precise control over the protein's amino acid sequence and structure, resulting in more predictable properties. Top Countries in Recombinant Human Hair Keratin Protein Market: United States Contribution: Leading the global market with strong demand for medical-grade recombinant keratin, supported by a robust biotech ecosystem and healthcare infrastructure. Strength: Advanced R&D capabilities and regulatory support for therapeutic and regenerative applications. China Contribution: Fastest-growing market, fueled by a rapidly expanding cosmetics and personal care sector. Strength: Strong domestic production capabilities, rising consumer awareness, and increasing investment in biotech innovations. Germany Contribution: Key contributor in Europe, especially in high-purity recombinant keratin for medical and cosmetic formulations. Strength: Expertise in biotechnology and demand for premium, high-performance personal care products. France Contribution: Strong market for cosmetic applications, particularly in haircare and skincare products incorporating natural bioactive ingredients. Strength: Sophisticated beauty industry and preference for sustainable, biologically derived ingredients. India Contribution: Emerging player in both medical and cosmetic applications of recombinant keratin. Strength: Large population base, rising demand for advanced hair and skin treatments, and growing domestic manufacturing activity. You can place an order or ask any questions, please feel free to contact us at sales@ What is the Growth Potential Responsible for The Growth of The Recombinant Human Hair Keratin Protein Market? The growth of the market is driven by the growing application in the biomedical field due to its biocompatibility, ability to promote cell growth, and biodegradability, which makes it ideal for various medical uses, driving the growth. The key applications, like tissue regeneration, drug delivery systems, and wound healing, are supporting the growth of the market. Other key drivers are biotechnology research due to the growing biotechnology sector, in personal care and cosmetics, and sustainable and ethical sourcing. Increasing incidence of chronic diseases, and government initiatives in R&D in life sciences research and development. What Are the Growing Trends Associated with the Recombinant Human Hair Keratin Protein Market? The technological advancements like innovation in synthetic biology and demonstration technology for the development of new and tailored properties, and more efficient production methods. Rising demand in the cosmetic sector for the development of hair care products for improving the shine, strengthening the damaged hair, and reducing the frizz increases the demand for the product. The growing biomedical applications, like in wound healing, tissue engineering, and drug delivery, fuel the demand for the product, supporting the growth. Shift towards sustainable and ethical products, like growing demand and interest in vegan and plant-based keratins, improves the market growth of the market. Increasing awareness and adoption due to the benefits offered and availability of the products make it a preferred choice, and increase the growth. What Is the Growing Challenge in the Recombinant Human Hair Keratin Protein Market? However, the recombinant human hair keratin protein market faces challenges including production issues, consistency concerns, and consumer perceptions. Although recombinant technology provides advantages like higher purity and specific amino acid composition, it also risks problems like misfolding, aggregation, and low yields. Additionally, high production costs, especially due to specialized equipment and chemicals, can hinder market growth. Consumer preferences for natural or plant-based products, along with safety and efficacy concerns regarding keratin treatments, could also limit market expansion. Get the latest insights on life science industry segmentation with our Annual Membership: Regional Analysis How Did North America Dominate the Recombinant Human Hair Keratin Protein Market in 2024? North America led the recombinant human hair keratin protein market in 2023. Growth is driven by increased investments, collaborations, key industry players, and advanced R&D activities. The US and Canada are the primary markets, with companies like Novus Biologicals, Abcam Ltd., PROGEN, and OriGene contributing significantly. US government initiatives to promote biotech research further boost the market, complemented by over 130 recombinant proteins approved by the US FDA for clinical use. In the UK, industries are exploring innovative methods to enhance hair growth, quality, and reduce hair fall using recombinant human hair keratin protein. Additionally, rising awareness about hair health is fueling demand for these products. What Made Asia Pacific Significantly Grow in The Recombinant Human Hair Keratin Protein Market in 2024? Asia-Pacific is expected to grow the fastest in the recombinant human hair keratin protein market during the forecast period. Market growth is driven by increasing research and development activities, rising government funding, a growing number of bleeding disorder cases, favorable infrastructure, and lower costs. Recombinant keratin has been shown to promote skin wound healing and improve blood clotting. In China, about 65,000 people suffer from hemophilia, while India has the second-largest number of hemophilia cases worldwide, with 136,000 patients. The demand for products that support hair growth and reduce hair loss is rapidly increasing in China, South Korea, and Japan. Companies like Tsubaki use recombinant human keratin to develop luxurious hair treatments that attract beauty-conscious consumers. Become a valued research partner with us - Recent Developments In July 2024, Yuhan Corp, a South Korean pharmaceutical company, signed a comprehensive R&D collaboration agreement with ProGen. The collaboration was made to strengthen next-generation biologics and drug development research. In April 2024, Bio-Techne Corporation announced a strategic distribution agreement with Thermo Fisher Scientific. The agreement will distribute Bio-Techne's innovative products, such as antibodies, proteins, immunoassay kits, reagents, and enzymes, to laboratories and research institutions across Europe. Browse More Insights of Towards Healthcare: The global GMP grade cytokines market is valued at USD 2.54 billion in 2024, expected to rise to USD 2.79 billion in 2025, and anticipated to reach approximately USD 6.48 billion by 2034. This represents a steady growth trajectory at a CAGR of 9.84% from 2025 to 2034. The global recombinant proteins market is estimated at USD 3.36 billion in 2025 and is forecasted to climb to around USD 8.08 billion by 2034, expanding at a CAGR of 10.24% over the forecast period. The recombinant lysyl endopeptidase market was valued at USD 38 million in 2023 and is projected to reach USD 67.06 million by 2034, growing at a CAGR of 5.3% between 2024 and 2034. The global hair transplant market stands at USD 7.33 billion in 2024, rising to USD 8.87 billion in 2025, with projections indicating a surge to nearly USD 49.44 billion by 2034—signaling rapid expansion. The hair treatment drug market was worth USD 1.4 billion in 2023 and is anticipated to grow to USD 2.99 billion by 2034, recording a CAGR of 7.14% during 2024–2034. The global host cell protein testing market is valued at USD 2.37 billion in 2024, estimated to increase to USD 2.56 billion in 2025, and forecasted to hit USD 5.19 billion by 2034, with an expected CAGR of 8.17% from 2025 to 2034. The global protein expression technology market is pegged at USD 2.85 billion in 2024, projected to rise to USD 3.05 billion in 2025, and likely to reach USD 5.58 billion by 2034, reflecting a CAGR of 6.94% over the forecast timeline. The global proteinase K market is valued at USD 4.82 billion in 2024, forecasted to grow to USD 5.23 billion in 2025, and set to reach USD 10.93 billion by 2034, advancing at a CAGR of 8.54% between 2025 and 2034. The global cell-free protein expression market is valued at USD 315.03 million in 2024, expected to grow to USD 342.25 million in 2025, and projected to hit USD 716.26 million by 2034, expanding at a CAGR of 8.63% from 2025 to 2034. The global protein therapeutics market is calculated at USD 375.3 billion in 2024, projected to grow to USD 401.89 billion in 2025, and expected to reach USD 740.07 billion by 2034, advancing at a CAGR of 7.08% over the forecast period. Recombinant Human Hair Keratin Protein Market Key Players Abcam Limited Abbexa, Ltd. Bon Opus Biosciences Creative Diagnostics MyBioSource, Inc. Novus Biologicals OriGene PROGEN ProSpec Wuhan Huamei Biotech Co., Ltd. Regions Covered North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: Immediate Delivery Available | Buy This Premium Research @ About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region - +44 778 256 0738 North America Region - +1 8044 4193 44 Web: Find us on social platforms: LinkedIn | Twitter | InstagramError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Causes, symptoms and how to prevent chikungunya - as cases rise in the UK
Causes, symptoms and how to prevent chikungunya - as cases rise in the UK

Yahoo

timean hour ago

  • Yahoo

Causes, symptoms and how to prevent chikungunya - as cases rise in the UK

Health authorities have warned of a "worrying increase" in cases of a mosquito-borne infection in people returning to the UK from abroad. of chikungunya were reported between January and June 2025 - more than double the 27 cases reported in the same period last year, the UK Health Agency (UKHSA) said. Data released by the agency also revealed three cases of oropouche virus, marking the first time the virus has been reported in the UK. Here is everything you need to know about both viruses, from symptoms to prevention and what could be behind the surge in cases. What is chikungunya? Chikungunya is a disease caused by a virus of the same name. It was first identified following an outbreak in Tanzania in 1952. The name is derived from a word in the Tanzanian language Makonde, and means "that which bends up", owing to the joint pain it can cause. It is spread by mosquito bites, specifically from yellow fever and tiger mosquitoes, in tropical and subtropical regions. What are the symptoms? Typical symptoms include fever, muscle pain, nausea, fatigue and a rash. The UKHSA says joint pain can persist for months or even years, with up to 12% of people still experiencing discomfort three years after infection. The majority of people who become infected recover within one to two weeks without needing medical attention. Serious complications are uncommon, and only very rare cases are fatal. Babies or elderly people with other underlying illnesses are the most vulnerable. The two mosquitoes known to transmit the disease, yellow fever and tiger, are not currently found in the UK. How does oropouche virus differ? Oropouche virus is spread predominantly by midge bites rather than mosquito bites. While bites from both insects can cause red itchy lumps on the skin, mosquito bites are generally larger and more painful, while midge bites are smaller and may last longer. Symptoms can be similar to chikungunya, and include joint paint, headache, chills, nausea and high fever. The UKHSA says anyone who becomes unwell with these symptoms after travelling should seek "urgent medical advice". Where can you catch the viruses? Regular outbreaks of chikungunya occur in Africa, Asia and the Americas, with occasional smaller instances in Europe. The UKHSA said the majority of the 73 reported cases from the first six months of this year reported travelling to Sri Lanka, India and Mauritius. The cases were linked to local outbreaks in the Indian Ocean region. As of last month, there have been about 240,000 cases of chikungunya - and 90 deaths - in 16 countries, according to the European Centres for Disease Prevention and Control (ECDC). Meanwhile, all the UK cases of oropouche virus were associated with travel to Brazil. Last year, 44 cases were reported in several European countries including Spain, Italy, France, Germany, Austria, Sweden and the Netherlands, according to the ECDC. China is currently experiencing the ever documented in the country, according to Cesar Lopez-Camacho of the University of Oxford. More than 7,000 cases have been reported since June, with 90% of those concentrated in Guangdong province, which borders Hong Kong. How to prepare before travelling Dr Philip Veal, a consultant in public health at UKHSA said it is "essential" for people to take precautions against mosquito bites when travelling. "Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk," he said. Checking the latest health advice on your destination before you travel is also recommended. The LSHTM added that people can do the following to reduce exposure to mosquito and midge bites:• Fit screens to windows and doors;• Avoid peak activity during dusk and dawn;• Get rid of any standing water where mosquitoes breed. There are also two vaccines for chikungunya approved for use in the UK: IXCHIQ, for people aged 18 to 59 and Vimkunya, for individuals 12 years and older. Both are available to buy privately from travel clinics after an assessment by a healthcare professional. Read more from Sky News: What's behind the increase in cases? The number of outbreaks of chikungunya has increased since 2000, Robert Jones, an assistant professor at the London School of Hygiene and Tropical Medicine (LSHTM) said. Mr Jones put this boom partly down to climate change and urban expansion. Dr Yang Liu, another professor at LSHTM, said the outbreak in China is not totally unexpected, but highlights the manifestation of a known risk, as yellow fever and tiger mosquitoes have been present in the area for many years.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store